SATO VICKI L
Insider CIK 1197020 · BMY Director · SYRS Director · VIR Director · DNLI Director · AKUS Director · ALLO Director · PKI Director · BWA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2026-06-18 | 2026-06-23 | 95,400 | — | $0 | 95,400 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2026-05-01 | 2026-05-04 | 22,000 | $10.05 | $221.1K | 1,078,391 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2026-04-01 | 2026-04-02 | 22,000 | $9.07 | $199.5K | 1,100,391 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2026-03-02 | 2026-03-03 | 21,800 | $9.50 | $207.1K | 1,122,591 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2026-03-02 | 2026-03-03 | 200 | $9.98 | $2.0K | 1,122,391 | SEC↗ |
| VIR Vir Biotechnology, Inc. | M Exercise deriv | 2026-02-24 | 2026-02-26 | 42,377 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 200 | $10.26 | $2.1K | 1,144,391 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 42,177 | $9.75 | $411.2K | 1,144,591 | SEC↗ |
| VIR Vir Biotechnology, Inc. | M Exercise | 2026-02-24 | 2026-02-26 | 42,377 | $1.49 | $63.1K | 1,186,768 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2026-02-02 | 2026-02-03 | 22,000 | $7.71 | $169.6K | 1,144,391 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2026-01-02 | 2026-01-05 | 22,000 | $5.93 | $130.5K | 1,166,391 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2025-12-01 | 2025-12-02 | 22,000 | $6.00 | $132.0K | 1,188,391 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2025-11-03 | 2025-11-04 | 22,000 | $5.64 | $124.1K | 1,210,391 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2025-10-01 | 2025-10-02 | 22,000 | $5.84 | $128.5K | 1,232,391 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2025-09-02 | 2025-09-03 | 22,000 | $4.99 | $109.8K | 1,254,391 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2025-08-01 | 2025-08-04 | 22,000 | $4.99 | $109.8K | 1,276,391 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2025-07-01 | 2025-07-02 | 22,000 | $5.10 | $112.2K | 1,298,391 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2025-06-18 | 2025-06-23 | 144,400 | — | $0 | 144,400 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2025-05-30 | 2025-06-02 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2025-05-30 | 2025-06-02 | 8,000 | — | $0 | 1,320,391 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2025-01-08 | 2025-01-08 | 10,960 | $12.52 | $137.2K | 1,312,391 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2025-01-02 | 2025-01-03 | 3,080 | $20.91 | $64.4K | 107,976 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-11-07 | 2024-11-12 | 1,020 | $30.00 | $30.6K | 111,056 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-11-01 | 2024-11-05 | 3,080 | $27.07 | $83.4K | 112,076 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-09-13 | 2024-09-16 | 1,020 | $30.00 | $30.6K | 115,156 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-09-03 | 2024-09-04 | 100 | $25.37 | $2.5K | 116,176 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-09-03 | 2024-09-04 | 2,980 | $24.99 | $74.5K | 116,276 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-07-01 | 2024-07-03 | 2,980 | $22.12 | $65.9K | 119,356 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-07-01 | 2024-07-03 | 100 | $22.86 | $2.3K | 119,256 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 95,541 | — | $0 | 95,541 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2024-06-05 | 2024-06-07 | 61,475 | — | $0 | 162,575 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2024-05-31 | 2024-06-04 | 17,901 | — | $0 | 17,901 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2024-05-31 | 2024-06-04 | 5,967 | — | $0 | 122,336 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2024-05-30 | 2024-06-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2024-05-30 | 2024-06-03 | 8,000 | — | $0 | 1,323,351 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-05-15 | 2024-05-17 | 1,674 | $20.39 | $34.1K | 116,369 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-04-15 | 2024-04-17 | 1,666 | $18.29 | $30.5K | 118,043 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-03-15 | 2024-03-19 | 1,666 | $20.10 | $33.5K | 119,709 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-02-15 | 2024-02-20 | 1,666 | $18.37 | $30.6K | 121,375 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-01-16 | 2024-01-18 | 1,666 | $18.42 | $30.7K | 123,041 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-12-15 | 2023-12-18 | 1,666 | $23.39 | $39.0K | 124,707 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-11-15 | 2023-11-16 | 1,666 | $19.13 | $31.9K | 126,373 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-10-16 | 2023-10-18 | 1,666 | $20.66 | $34.4K | 128,039 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-09-15 | 2023-09-19 | 40 | $24.35 | $974 | 129,705 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-09-15 | 2023-09-19 | 1,626 | $23.60 | $38.4K | 129,745 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-08-15 | 2023-08-17 | 1,666 | $24.30 | $40.5K | 131,371 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-07-17 | 2023-07-19 | 1,666 | $29.60 | $49.3K | 133,037 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-06-30 | 2023-07-03 | 18,000 | $24.66 | $443.9K | 1,315,351 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-06-28 | 2023-06-30 | 1,114 | $29.98 | $33.4K | 134,703 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-06-28 | 2023-06-30 | 552 | $29.55 | $16.3K | 135,817 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2023-06-13 | 2023-06-15 | 23,224 | — | $0 | 23,224 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2023-06-13 | 2023-06-15 | 59,649 | — | $0 | 101,100 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 12,649 | — | $0 | 12,649 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2023-06-01 | 2023-06-05 | 4,216 | — | $0 | 136,369 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2023-05-22 | 2023-05-24 | 12,054 | — | $0 | 12,054 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2023-05-22 | 2023-05-24 | 6,027 | — | $0 | 1,333,351 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-03-08 | 2023-03-09 | 17,935 | $22.59 | $405.2K | 1,327,324 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-02-08 | 2023-02-09 | 627 | $29.00 | $18.2K | 1,345,259 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-02-08 | 2023-02-09 | 17,288 | $28.35 | $490.1K | 1,345,886 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-01-09 | 2023-01-11 | 17,915 | $25.83 | $462.7K | 1,363,174 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-12-08 | 2022-12-09 | 17,915 | $25.81 | $462.4K | 1,381,089 | SEC↗ |
| AKUS Akouos, Inc. | D To issuer deriv | 2022-12-01 | 2022-12-02 | 16,000 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | D To issuer deriv | 2022-12-01 | 2022-12-02 | 12,100 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | D To issuer deriv | 2022-12-01 | 2022-12-02 | 26,930 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-11-08 | 2022-11-09 | 17,915 | $27.38 | $490.5K | 1,399,004 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-10-10 | 2022-10-11 | 17,915 | $20.67 | $370.3K | 1,416,919 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-09-08 | 2022-09-09 | 17,915 | $21.90 | $392.3K | 1,434,834 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-08-08 | 2022-08-09 | 17,915 | $30.29 | $542.6K | 1,452,749 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-07-08 | 2022-07-12 | 5,072 | $29.57 | $150.0K | 1,470,664 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-07-08 | 2022-07-12 | 12,843 | $28.87 | $370.8K | 1,475,736 | SEC↗ |
| AKUS Akouos, Inc. | A Award deriv | 2022-06-23 | 2022-06-27 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2022-06-15 | 2022-06-17 | 35,535 | $9.62 | $341.8K | 35,535 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2022-06-15 | 2022-06-17 | 22,089 | — | $0 | 41,451 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-06-08 | 2022-06-09 | 500 | $26.51 | $13.3K | 1,488,579 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-06-08 | 2022-06-09 | 17,415 | $25.82 | $449.7K | 1,489,079 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 17,959 | — | $0 | 17,959 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2022-06-02 | 2022-06-06 | 5,986 | — | $0 | 142,149 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-05-24 | 2022-05-25 | 3,374 | $23.82 | $80.4K | 1,506,494 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2022-05-23 | 2022-05-25 | 12,810 | — | $0 | 12,810 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2022-05-23 | 2022-05-25 | 6,405 | — | $0 | 1,509,868 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-05-09 | 2022-05-10 | 14,541 | $20.62 | $299.8K | 1,503,463 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-04-28 | 2022-05-02 | 14,093 | $20.74 | $292.3K | 1,521,826 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-04-28 | 2022-05-02 | 3,822 | $21.49 | $82.1K | 1,518,004 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-01-18 | 2022-01-20 | 15,173 | $37.39 | $567.3K | 1,535,919 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-12-20 | 2021-12-21 | 5,200 | $55.38 | $288.0K | 1,554,593 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-12-20 | 2021-12-21 | 1,100 | $56.10 | $61.7K | 1,553,493 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-12-20 | 2021-12-21 | 2,401 | $57.82 | $138.8K | 1,551,092 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-12-20 | 2021-12-21 | 1,300 | $54.35 | $70.7K | 1,559,793 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-12-20 | 2021-12-21 | 5,173 | $51.87 | $268.3K | 1,561,093 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-11-26 | 2021-11-30 | 15,174 | $36.80 | $558.4K | 1,566,266 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-11-10 | 2021-11-12 | 660 | $53.30 | $35.2K | 126,167 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-11-10 | 2021-11-12 | 1,006 | $52.49 | $52.8K | 126,827 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-11-01 | 2021-11-03 | 1,666 | $50.05 | $83.4K | 127,833 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-10-19 | 2021-10-20 | 6,671 | $39.12 | $261.0K | 1,589,943 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-10-19 | 2021-10-20 | 8,503 | $39.91 | $339.4K | 1,581,440 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-09-17 | 2021-09-21 | 11,775 | $52.31 | $616.0K | 1,600,013 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-09-17 | 2021-09-21 | 3,399 | $53.06 | $180.4K | 1,596,614 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-09-15 | 2021-09-17 | 676 | $53.03 | $35.8K | 130,259 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-09-15 | 2021-09-17 | 620 | $53.92 | $33.4K | 129,639 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-09-15 | 2021-09-17 | 140 | $54.76 | $7.7K | 129,499 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-09-15 | 2021-09-17 | 230 | $52.28 | $12.0K | 130,935 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-08-19 | 2021-08-23 | 9,045 | $45.52 | $411.7K | 1,611,788 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-08-19 | 2021-08-23 | 6,129 | $44.36 | $271.9K | 1,620,833 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-18 | 2021-08-20 | 860 | $52.12 | $44.8K | 131,165 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-18 | 2021-08-20 | 806 | $51.26 | $41.3K | 132,025 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2021-07-30 | 2021-08-03 | 31,692 | — | $0 | 31,692 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2021-07-30 | 2021-08-03 | 19,362 | — | $0 | 19,362 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-07-21 | 2021-07-23 | 400 | $65.78 | $26.3K | 132,831 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-07-21 | 2021-07-23 | 866 | $65.24 | $56.5K | 133,231 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-07-21 | 2021-07-23 | 400 | $64.25 | $25.7K | 134,097 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-07-19 | 2021-07-20 | 6,363 | $37.84 | $240.8K | 1,626,962 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-07-19 | 2021-07-20 | 8,811 | $36.74 | $323.7K | 1,633,325 | SEC↗ |
| AKUS Akouos, Inc. | A Award deriv | 2021-06-24 | 2021-06-25 | 16,000 | — | $0 | 16,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-06-23 | 2021-06-24 | 986 | $71.11 | $70.1K | 134,497 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-06-23 | 2021-06-24 | 680 | $70.20 | $47.7K | 135,483 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-06-21 | 2021-06-22 | 11,881 | $46.00 | $546.5K | 1,645,429 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-06-21 | 2021-06-22 | 3,293 | $46.75 | $153.9K | 1,642,136 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-06-02 | 2021-06-04 | 6,222 | — | $0 | 6,222 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2021-06-02 | 2021-06-04 | 2,074 | — | $0 | 136,163 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-26 | 2021-05-28 | 40 | $66.72 | $2.7K | 134,089 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-26 | 2021-05-28 | 894 | $64.90 | $58.0K | 134,861 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-26 | 2021-05-28 | 732 | $65.88 | $48.2K | 134,129 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2021-05-21 | 2021-05-25 | 6,748 | — | $0 | 6,748 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2021-05-21 | 2021-05-25 | 3,374 | — | $0 | 1,657,310 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-05-19 | 2021-05-20 | 1,443 | $44.96 | $64.9K | 1,653,936 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-05-19 | 2021-05-20 | 8,328 | $43.35 | $361.0K | 1,660,782 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2021-05-19 | 2021-05-20 | 5,403 | $44.18 | $238.7K | 1,655,379 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-04-28 | 2021-04-30 | 381 | $60.71 | $23.1K | 137,040 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-04-28 | 2021-04-30 | 597 | $62.05 | $37.0K | 136,443 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-04-28 | 2021-04-30 | 688 | $63.03 | $43.4K | 135,755 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-31 | 2021-04-01 | 635 | $56.92 | $36.1K | 137,557 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-31 | 2021-04-01 | 18 | $54.38 | $979 | 139,069 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-31 | 2021-04-01 | 877 | $55.91 | $49.0K | 138,192 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-31 | 2021-04-01 | 136 | $57.61 | $7.8K | 137,421 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-03 | 2021-03-04 | 266 | $62.29 | $16.6K | 139,202 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-03 | 2021-03-04 | 1,050 | $61.52 | $64.6K | 139,468 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-03 | 2021-03-04 | 235 | $60.36 | $14.2K | 140,518 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-03 | 2021-03-04 | 115 | $63.37 | $7.3K | 139,087 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2021-02-01 | 2021-02-03 | 3,054 | $62.21 | $190.0K | 75,689 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 15,183 | — | $0 | 15,183 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 3,253 | — | $0 | 3,253 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2020-05-21 | 2020-10-13 | 23,649 | — | $0 | 23,649 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 28,888 | — | $0 | 28,888 | SEC↗ |
| BWA BORGWARNER INC | A Award | 2020-04-29 | 2020-05-01 | 4,382 | $29.67 | $130.0K | 19,823 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2020-02-01 | 2020-02-04 | 3,018 | $62.95 | $190.0K | 70,460 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2019-10-10 | 2019-10-11 | 22,222 | — | $0 | 22,222 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2019-06-11 | 2019-06-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2019-05-30 | 2019-05-31 | 27,245 | — | $0 | 27,245 | SEC↗ |
| BWA BORGWARNER INC | A Award | 2019-04-24 | 2019-05-08 | 2,985 | $43.55 | $130.0K | 15,404 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2019-02-01 | 2019-02-05 | 3,708 | $49.89 | $185.0K | 65,318 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2018-06-14 | 2018-06-15 | 11,000 | — | $0 | 11,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 27,830 | — | $0 | 27,830 | SEC↗ |
| BWA BORGWARNER INC | A Award | 2018-04-25 | 2018-04-27 | 2,457 | $52.91 | $130.0K | 12,378 | SEC↗ |
| BWA BORGWARNER INC | A Award | 2018-04-25 | 2018-05-01 | 2,457 | $52.91 | $130.0K | 12,378 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2018-02-01 | 2018-02-05 | 2,946 | $62.80 | $185.0K | 59,784 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-12 | 62,500 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-12 | 62,500 | — | $0 | 137,500 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2017-12-07 | 2017-12-08 | 47,165 | — | $0 | 47,165 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-06-08 | 2017-09-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-06-08 | 2017-06-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| BWA BORGWARNER INC | A Award | 2017-04-26 | 2017-04-28 | 2,991 | $41.13 | $123.0K | 9,921 | SEC↗ |
| PKI PERKINELMER INC | M Exercise deriv | 2017-02-09 | 2017-02-10 | 8,308 | — | $0 | 0 | SEC↗ |
| PKI PERKINELMER INC | S Sale | 2017-02-09 | 2017-02-10 | 8,308 | $54.01 | $448.7K | 29,970 | SEC↗ |
| PKI PERKINELMER INC | M Exercise | 2017-02-09 | 2017-02-10 | 8,308 | $23.36 | $194.1K | 38,278 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2017-02-01 | 2017-02-03 | 3,449 | $49.29 | $170.0K | 55,356 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2016-09-15 | 2016-09-19 | 22,000 | — | $0 | 22,000 | SEC↗ |
| PKI PERKINELMER INC | A Award | 2016-05-10 | 2016-05-12 | 1,821 | — | $0 | 29,970 | SEC↗ |
| PKI PERKINELMER INC | A Award | 2016-05-10 | 2016-05-12 | 1,373 | — | $0 | 28,149 | SEC↗ |
| PKI PERKINELMER INC | S Sale | 2016-05-10 | 2016-05-12 | 2,402 | $53.89 | $129.4K | 36,960 | SEC↗ |
| PKI PERKINELMER INC | S Sale | 2016-05-10 | 2016-05-12 | 10,184 | $54.65 | $556.6K | 26,776 | SEC↗ |
| BWA BORGWARNER INC | A Award | 2016-04-27 | 2016-04-29 | 3,131 | $39.29 | $123.0K | 6,930 | SEC↗ |
| PKI PERKINELMER INC | M Exercise deriv | 2016-04-26 | 2016-04-27 | 12,586 | — | $0 | 0 | SEC↗ |
| PKI PERKINELMER INC | M Exercise | 2016-04-26 | 2016-04-27 | 12,586 | $17.40 | $219.0K | 39,362 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2016-02-01 | 2016-02-03 | 2,795 | $60.82 | $170.0K | 50,596 | SEC↗ |
| PKI PERKINELMER INC | A Award | 2015-05-05 | 2015-05-07 | 1,080 | — | $0 | 24,823 | SEC↗ |
| PKI PERKINELMER INC | A Award | 2015-05-05 | 2015-05-07 | 1,953 | — | $0 | 26,776 | SEC↗ |
| BWA BORGWARNER INC | A Award | 2015-04-29 | 2015-05-01 | 1,887 | $60.95 | $115.0K | 3,777 | SEC↗ |
| PKI PERKINELMER INC | S Sale | 2015-02-10 | 2015-02-11 | 16,800 | $45.56 | $765.4K | 23,743 | SEC↗ |
| PKI PERKINELMER INC | S Sale | 2015-02-09 | 2015-02-11 | 7,200 | $45.53 | $327.8K | 40,543 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2015-02-01 | 2015-02-03 | 2,655 | $60.27 | $160.0K | 46,705 | SEC↗ |
| BWA BORGWARNER INC | A Award | 2014-04-30 | 2014-05-02 | 1,873 | $61.40 | $115.0K | 1,873 | SEC↗ |
| PKI PERKINELMER INC | A Award deriv | 2014-04-29 | 2014-05-01 | 4,750 | — | $0 | 4,750 | SEC↗ |
| PKI PERKINELMER INC | A Award | 2014-04-29 | 2014-05-01 | 2,373 | — | $0 | 47,743 | SEC↗ |
| PKI PERKINELMER INC | M Exercise deriv | 2014-02-14 | 2014-02-18 | 7,097 | — | $0 | 0 | SEC↗ |
| PKI PERKINELMER INC | M Exercise deriv | 2014-02-14 | 2014-02-18 | 5,854 | — | $0 | 0 | SEC↗ |
| PKI PERKINELMER INC | M Exercise deriv | 2014-02-14 | 2014-02-18 | 8,892 | — | $0 | 0 | SEC↗ |
| PKI PERKINELMER INC | M Exercise | 2014-02-14 | 2014-02-18 | 8,892 | $26.49 | $235.5K | 67,213 | SEC↗ |
| PKI PERKINELMER INC | M Exercise | 2014-02-14 | 2014-02-18 | 5,854 | $19.91 | $116.6K | 51,224 | SEC↗ |
| PKI PERKINELMER INC | M Exercise | 2014-02-14 | 2014-02-18 | 7,097 | $24.27 | $172.2K | 58,321 | SEC↗ |
| PKI PERKINELMER INC | S Sale | 2014-02-14 | 2014-02-18 | 21,843 | $43.97 | $960.4K | 45,370 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2014-02-01 | 2014-02-04 | 3,192 | $50.12 | $160.0K | 42,603 | SEC↗ |
| PKI PERKINELMER INC | M Exercise deriv | 2013-04-30 | 2013-05-02 | 6,440 | — | $0 | 0 | SEC↗ |
| PKI PERKINELMER INC | A Award deriv | 2013-04-30 | 2013-05-02 | 5,601 | — | $0 | 5,601 | SEC↗ |
| PKI PERKINELMER INC | M Exercise | 2013-04-30 | 2013-05-02 | 6,440 | $21.67 | $139.6K | 48,547 | SEC↗ |
| PKI PERKINELMER INC | S Sale | 2013-04-30 | 2013-05-02 | 6,440 | $30.53 | $196.6K | 42,107 | SEC↗ |
| PKI PERKINELMER INC | A Award | 2013-04-30 | 2013-05-02 | 3,263 | — | $0 | 45,370 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2013-02-01 | 2013-02-05 | 4,364 | $36.66 | $160.0K | 38,500 | SEC↗ |
| PKI PERKINELMER INC | A Award deriv | 2012-05-01 | 2012-05-03 | 7,071 | — | $0 | 7,071 | SEC↗ |
| PKI PERKINELMER INC | A Award | 2012-05-01 | 2012-05-03 | 3,580 | — | $0 | 42,107 | SEC↗ |
| PKI PERKINELMER INC | M Exercise deriv | 2012-02-08 | 2012-02-10 | 5,865 | — | $0 | 0 | SEC↗ |
| PKI PERKINELMER INC | M Exercise | 2012-02-08 | 2012-02-10 | 5,865 | $19.87 | $116.5K | 44,392 | SEC↗ |
| PKI PERKINELMER INC | S Sale | 2012-02-08 | 2012-02-10 | 5,865 | $26.13 | $153.3K | 38,527 | SEC↗ |
| BMY BRISTOL MYERS SQUIBB CO | A Award deriv | 2012-02-01 | 2012-02-03 | 4,313 | $32.46 | $140.0K | 32,828 | SEC↗ |